Manali Kamdar obtained her medical degree from Mumbai, India, and subsequently completed a residency in Internal Medicine and a fellowship in Hematology and Oncology at the East Carolina University in Greenville, North Carolina. She then completed another fellowship in lymphoid malignancies and bone marrow transplantation at Stanford University.
Subspecializing in lymphomas appealed to Manali Kamdar because of the clinical heterogeneity with each subtype, scientifically stimulating biology, opportunity to tailor therapeutics, and the endless possibilities of new drug development.
Currently, Manali Kamdar is an Associate Professor of Medicine at the University of Colorado School of Medicine and serve as the Clinical Director of the lymphoma program. Her clinical and research interests include Bcell lymphomas, particularly refractory diffuse large B-cell lymphoma, mantle cell lymphomas, and other indolent lymphomas.
In addition to seeing patients with lymphoma in clinic, Manali Kamdars research involves conducting clinical trials of novel drugs, including immunotherapy and combinations in these diseases.
Manali Kamdar has had the opportunity to serve in organizations at the national level. This includes working with the National Comprehensive Cancer Network guidelines committee and Southwest Oncology Group lymphoma committee, where she serves as a cadre member of the chronic lymphocytic leukemia and lymphoma working groups, respectively.
Manali Kamdars goal is to develop nuanced approaches of personalized medicine in lymphoid malignancies, and she is currently collaborating with several clinical as well as laboratory-based investigators in the United States. Her eventual hope is to make these fascinating discoveries efficacious, durable, and affordable so that they have a far-reaching impact on patients everywhere.